Treatment of acute myeloid leukaemia in a renal allograft recipient: implications of cyclosporin immunosuppressive treatment.
The clinical effects of cyclosporin were evaluated during cytotoxic treatment in a 61 year old man with acute myeloid leukaemia. He had required a renal transplant 18 months before presenting with acute myeloid leukaemia (FAB subtype M4). He had received cyclosporin 3.5-4.0 mg/kg daily to maintain a...
Guardat en:
| Publicat a: | J Clin Pathol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1991
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC496770/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1890206/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.44.8.693 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
